AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of the therapies for the treatment of moderate to severe acute pain. Its main product candidates include Dsuvia, Zalviso, and ARX-04. The company generates the revenue from collaboration agreements which includes license fees, cost reimbursement, development and manufacturing services, payments and royalties.